{
  "resourceType": "ValueSet",
  "id": "2.16.840.1.113883.3.464.1003.110.12.1043",
  "meta": {
    "versionId": "23",
    "lastUpdated": "2022-03-02T18:04:17.000-05:00",
    "profile": [
      "http://hl7.org/fhir/StructureDefinition/shareablevalueset",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
    ]
  },
  "extension": [
    {
      "url": "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
      "valueDate": "2022-03-02"
    }
  ],
  "url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.12.1043",
  "identifier": [
    {
      "system": "urn:ietf:rfc:3986",
      "value": "urn:oid:2.16.840.1.113883.3.464.1003.110.12.1043"
    }
  ],
  "version": "20170504",
  "name": "Haemophilus Influenzae Type B (Hib) Vaccine Administered",
  "title": "Haemophilus Influenzae Type B (Hib) Vaccine Administered",
  "status": "active",
  "experimental": false,
  "date": "2022-03-03T18:46:01-05:00",
  "publisher": "NCQA PHEMUR",
  "compose": {
    "include": [
      {
        "system": "http://snomed.info/sct",
        "concept": [
          {
            "code": "127787002",
            "display": "Administration of vaccine product containing only Haemophilus influenzae type b antigen (procedure)"
          },
          {
            "code": "16292241000119109",
            "display": "Administration of booster dose of vaccine product containing only Haemophilus influenzae type b capsular polysaccharide polyribosylribitol phosphate conjugated to Clostridium tetani toxoid protein (procedure)"
          },
          {
            "code": "170343007",
            "display": "Administration of first dose of vaccine product containing only Haemophilus influenzae type b antigen (procedure)"
          },
          {
            "code": "170344001",
            "display": "Administration of second dose of vaccine product containing only Haemophilus influenzae type b antigen (procedure)"
          },
          {
            "code": "170345000",
            "display": "Administration of third dose of vaccine product containing only Haemophilus influenzae type b antigen (procedure)"
          },
          {
            "code": "170346004",
            "display": "Administration of booster dose of vaccine product containing only Haemophilus influenzae type b antigen (procedure)"
          },
          {
            "code": "310306005",
            "display": "Administration of first dose of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Human poliovirus antigens (procedure)"
          },
          {
            "code": "310307001",
            "display": "Administration of second dose of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Human poliovirus antigens (procedure)"
          },
          {
            "code": "310308006",
            "display": "Administration of third dose of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Human poliovirus antigens (procedure)"
          },
          {
            "code": "312869001",
            "display": "Administration of vaccine product containing only Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Human poliovirus antigens (procedure)"
          },
          {
            "code": "312870000",
            "display": "Administration of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Human poliovirus antigens (procedure)"
          },
          {
            "code": "414001002",
            "display": "Administration of vaccine product containing only five component acellular Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and inactivated whole Human poliovirus antigens (procedure)"
          },
          {
            "code": "414259000",
            "display": "Administration of first dose of vaccine product containing only five component acellular Bordetella pertussis, Clostridium tetani, Corynebacterium diphtheriae, Haemophilus influenzae type b and inactivated whole Human poliovirus antigens (procedure)"
          },
          {
            "code": "415507003",
            "display": "Administration of second dose of vaccine product containing only five component acellular Bordetella pertussis, Clostridium tetani, Corynebacterium diphtheriae, Haemophilus influenzae type b and inactivated whole Human poliovirus antigens (procedure)"
          },
          {
            "code": "415712004",
            "display": "Administration of third dose of vaccine product containing only five component acellular Bordetella pertussis, Clostridium tetani, Corynebacterium diphtheriae, Haemophilus influenzae type b and inactivated whole Human poliovirus antigens (procedure)"
          },
          {
            "code": "770608009",
            "display": "Administration of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Hepatitis B virus antigens (procedure)"
          },
          {
            "code": "770616000",
            "display": "Administration of first dose of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Hepatitis B virus antigens (procedure)"
          },
          {
            "code": "770617009",
            "display": "Administration of second dose of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Hepatitis B virus antigens (procedure)"
          },
          {
            "code": "770618004",
            "display": "Administration of third dose of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Hepatitis B virus antigens (procedure)"
          },
          {
            "code": "786846001",
            "display": "Administration of vaccine product containing only Haemophilus influenzae type b and Hepatitis B virus antigens (procedure)"
          },
          {
            "code": "787436003",
            "display": "Administration of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b antigens (procedure)"
          }
        ]
      },
      {
        "system": "http://www.ama-assn.org/go/cpt",
        "concept": [
          {
            "code": "90644",
            "display": "Meningococcal conjugate vaccine, serogroups C & Y and Haemophilus influenzae type b vaccine (Hib-MenCY), 4 dose schedule, when administered to children 6 weeks-18 months of age, for intramuscular use"
          },
          {
            "code": "90647",
            "display": "Haemophilus influenzae type b vaccine (Hib), PRP-OMP conjugate, 3 dose schedule, for intramuscular use"
          },
          {
            "code": "90648",
            "display": "Haemophilus influenzae type b vaccine (Hib), PRP-T conjugate, 4 dose schedule, for intramuscular use"
          },
          {
            "code": "90697",
            "display": "Diphtheria, tetanus toxoids, acellular pertussis vaccine, inactivated poliovirus vaccine, Haemophilus influenzae type b PRP-OMP conjugate vaccine, and hepatitis B vaccine (DTaP-IPV-Hib-HepB), for intramuscular use"
          },
          {
            "code": "90698",
            "display": "Diphtheria, tetanus toxoids, acellular pertussis vaccine, Haemophilus influenzae type b, and inactivated poliovirus vaccine, (DTaP-IPV/Hib), for intramuscular use"
          },
          {
            "code": "90748",
            "display": "Hepatitis B and Haemophilus influenzae type b vaccine (Hib-HepB), for intramuscular use"
          }
        ]
      }
    ]
  }
}